Preclinical Evidence of Curcuma longa and Its Noncurcuminoid Constituents against Hepatobiliary Diseases: A Review

Figure 3

Pharmacological activities of four chemical compounds from C. longa. Four sorts of noncurcuminoid ingredients obtained from C. longa showed hepatoprotective effects commonly. Among them, β-elemene could be an attractive compound to treat different hepatobiliary diseases because it was excellent in anti-inflammatory, antifibrotic, and antitumor activities, as well as hepatoprotective effects.